The Rhode Island Blood Center must collect 250 pints of volunteer blood every day in order to meet the needs of its community. Although community members are consistently generous, the Center had to find an efficient way for these people to support the cause. The result: More than 3,000 mobile blood drives annually, scattered throughout […]
It’s been nearly two-and-a-half decades since the gene associated with the inherited disease cystic fibrosis was discovered, paving the way for disease-modifying drugs. In that time, only one such drug has been approved in the U.S. and Europe — Vertex’s Kalydeco. And that drug is only approved for the 4 percent of CF patients who […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Mnemosyne Pharmaceuticals gets its offbeat name from the Greek goddess of memory. It’s fitting because the Providence, Rhode Island startup is hoping to improve memory and cognitive function in patients with neuropsychiatric conditions by modulating a receptor call N-Methyl-D-Aspartate, or more commonly, NMDA. NMDA receptors have long been thought to be the master switches for […]
A healthcare IT startup has developed a mobile collaboration solution to improve communication between the team of doctors, nurses and healthcare professionals associated with a patient’s care to reduce medical errors. Scott Guelich, a software developer who also has a medical degree, co-founded Care Thread 12 months ago to address problems where they happen most […]
C.R. Bard Inc. (NYSE:BCR) will pay $184 million to settle most of the lawsuits against subsidiary Davol Inc.’s hernia repair products. Through late last year, more than 2,700 plaintiffs had filed suit in either federal or state courts pursuing product-liability claims for personal injuries, with most of those cases since transferred to the U.S. District […]
The XenMatrix FDA recall says the hernia and abdominal wall repair product has high levels of endotoxins. Davol is a subsidiary of C.R. Bard.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Cardiac device maker Neograft Technologies is developing new innovative medical devices focused on coronary artery bypass graft surgery, a procedure in which a blood vessel is typically removed from a patient's arm or leg and placed around a blockage in the heart to "bypass" the blockage and restore blood flow. The implanted blood vessel is called a graft. If the Angioshield is proven to be effective, its potential market is very large. About half-a-million coronary artery bypass surgeries are performed annually in the U.S. In addition, there are approximately 80,000 lower extremity bypass graft surgeries performed each year in the country. Revenue generated by products in the procedures totals about $1.6 billion annually, according to the company.